Headquarters
3900 ESSEX LN STE 575, HOUSTON, TX 77027-5175, US
HOUSTON, TX, US
ALLTERUM THERAPEUTICS, INC.
From the company
Allterum Therapeutics is an early-stage biotechnology company developing precision oncology and inflammation therapeutics. Its lead program, 4A10, is an anti-CD127 monoclonal antibody targeting the CD127 pathway (IL-7 receptor complex) for relapsed leukemia, acute lymphoblastic leukemia, B-cell malignancies, lymphomas, and CD127-expressing solid tumors. The 4A10 antibody was developed at the National Cancer Institute and licensed exclusively to Fannin; Allterum is a Fannin portfolio company.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.